We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+16.26%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.58B
AUM Growth
+$476M
Cap. Flow
-$79.2M
Cap. Flow %
-1.73%
Top 10 Hldgs %
7.86%
Holding
734
New
63
Increased
245
Reduced
365
Closed
52

Sector Composition

Rank Sector Weight
1 Industrials 20.81%
2 Financials 20.14%
3 Technology 12.67%
4 Healthcare 11.12%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HXL icon
501
Hexcel
HXL
$7.64B
$1.75M 0.04%
23,740
-11,781
-33% -$796K
HBIO icon
502
Harvard Bioscience
HBIO
$28.5M
$1.75M 0.04%
32,629
-506
-2% -$22.8K
TITN icon
503
Titan Machinery
TITN
$443M
$1.72M 0.04%
59,462
-1,033
-2% -$26.8K
DAR icon
504
Darling Ingredients
DAR
$9.91B
$1.72M 0.04%
34,438
+4,607
+15% +$209K
CLAR icon
505
Clarus
CLAR
$150M
$1.7M 0.04%
247,041
-3,829
-2% -$22.5K
CCK icon
506
Crown Holdings
CCK
$13.2B
$1.7M 0.04%
18,490
-15,580
-46% -$1.32M
NRIX icon
507
Nurix Therapeutics
NRIX
$2.66B
$1.66M 0.04%
161,011
-2,612
-2% -$17.9K
PERI icon
508
Perion Network
PERI
$398M
$1.66M 0.04%
53,816
-1,473
-3% -$41.8K
ARKO icon
509
ARKO Corp
ARKO
$506M
$1.66M 0.04%
200,971
-3,221
-2% -$24.7K
CBSH icon
510
Commerce Bancshares
CBSH
$8.46B
$1.65M 0.04%
34,014
-6,974
-17% -$301K
JILL icon
511
J. Jill
JILL
$276M
$1.64M 0.04%
+63,493
New +$1.8M
KURA icon
512
Kura Oncology
KURA
$863M
$1.64M 0.04%
113,715
+34,197
+43% +$336K
CGEM icon
513
Cullinan Oncology
CGEM
$1.21B
$1.63M 0.04%
160,012
-329,434
-67% -$2.92M
AIR icon
514
AAR Corp
AIR
$5.89B
$1.62M 0.04%
26,030
-5,902
-18% -$379K
XPER icon
515
Xperi
XPER
$329M
$1.62M 0.04%
147,190
-2,977
-2% -$28.7K
ZYME icon
516
Zymeworks
ZYME
$1.72B
$1.62M 0.04%
156,034
-2,641
-2% -$21K
ITGR icon
517
Integer Holdings
ITGR
$4.26B
$1.59M 0.03%
16,075
-1,832
-10% -$158K
HURC icon
518
Hurco Companies Inc
HURC
$141M
$1.57M 0.03%
73,113
-1,227
-2% -$25.5K
DVAX
519
DELISTED
Dynavax Technologies
DVAX
$1.57M 0.03%
112,275
-1,768
-2% -$24.6K
MLR icon
520
Miller Industries
MLR
$614M
$1.52M 0.03%
+35,854
New +$1.41M
CPT icon
521
Camden Property Trust
CPT
$10.9B
$1.51M 0.03%
15,206
-1,076
-7% -$99.7K
ASTH icon
522
Astrana Health
ASTH
$1.81B
$1.46M 0.03%
38,247
-725
-2% -$24.1K
AMN icon
523
AMN Healthcare
AMN
$1.34B
$1.46M 0.03%
19,520
-21,070
-52% -$1.51M
CORT icon
524
Corcept Therapeutics
CORT
$12.3B
$1.46M 0.03%
+44,929
New +$1.23M
TER icon
525
Teradyne
TER
$60.1B
$1.46M 0.03%
13,432
+1,302
+11% +$124K

Similar funds

Kennedy Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Kennedy Capital Management held 734 positions worth $4.58B, up 12% from $4.1B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Kennedy Capital Management's Q4 2023 filing shows 63 new, 245 increased, 365 reduced and 52 closed positions. Its largest new stake was Silicon Motion: 128,520 shares worth $7.87M. The largest sale was NextGen Healthcare, Inc. Common Stock, an estimated $18.7M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

  • Kennedy Capital Management's largest Q4 2023 buy was Silicon Motion: 128,520 shares worth $7.87M.
  • Kennedy Capital Management added most to Barnes Group Inc. in Q4 2023, an estimated $17.5M increase.
  • Kennedy Capital Management's biggest Q4 2023 reduction was Perficient Inc, cutting an estimated $10.6M.
  • Kennedy Capital Management fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $18.7M.
  • Kennedy Capital Management's ten largest holdings make up 7.9% of its $4.58B portfolio in Q4 2023.
  • Kennedy Capital Management opened 63 new positions and closed 52 in Q4 2023.
  • Kennedy Capital Management's portfolio value rose 12% quarter-over-quarter to $4.58B.

Based on Kennedy Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.